Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2

This publication has 17 references indexed in Scilit:

• SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
  Published by Wiley ,2001
• Chronic ▵⁹‐Tetrahydrocannabinol Treatment Produces a Time‐Dependent Loss of Cannabinoid Receptors and Cannabinoid Receptor‐Activated G Proteins in Rat Brain
  Journal of Neurochemistry, 1999
• Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPγS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide
  Neurochemistry International, 1999
• Cannabis dependence, withdrawal, and reinforcing effects among adolescents with conduct symptoms and substance use disorders1Presented in part at the National Marijuana Conference of the National Institute on Drug Abuse, Washington, D.C., on 20 July 1995.1
  Drug and Alcohol Dependence, 1998
• Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
  Science, 1997
• SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
  European Journal of Pharmacology, 1997
• Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A
  European Journal of Pharmacology, 1995
• Physical withdrawal in rats tolerant to Δ9-tetrahydrocannabinol precipitated by a cannabinoid receptor antagonist
  European Journal of Pharmacology, 1995
• Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
  Science, 1992
• CLINICAL STUDIES OF CANNABIS TOLERANCE AND DEPENDENCE*
  Annals of the New York Academy of Sciences, 1976